Wilson disease combined with polycystic ovary syndrome–clinical features, treatment, and outcome in Chinese patients

Table 2 Laboratory data of PCOS-WD group vs. PCOS-NWD group

Parameter	Total (n = 83) Median (IQR)	PCOS-WD group (n = 40) vs. PCOS-NWD group (n = 43)
Parameter	Total (n = 83) Median (IQR)	Z	P
Testosterone	0.74(1.12)	-2.306	0.021
Prolactin	24.67(12.00)	-0.150	0.880
Progesterone	0.48(0.69)	-0.273	0.785
LH	11.6(8.84)	-1.221	0.222
FSH	6.47(2.71)	-2.452	0.014
LH/FSH	1.9(1.71)	2.443	0.015
E2	68.46(49.98)	-1.682	0.093
Glucose	4.96(0.76)	-1.773	0.076
TC	4.25(1.23)	-0.036	0.971
TG	0.98(0.51)	-1.705	0.088

Note: PCOS = polycystic ovary syndrome, PCOS-WD = polycystic ovary syndrome combined with Wilson disease, PCOS-NWD = polycystic ovary syndrome not combined with Wilson disease, IQR = Inter-Quartile Range, LH = luteinizing hormone, FSH = follicle-stimulating hormone, E2 = estradiol, TC = total cholesterol, TG = triglyceride

ISSN: 1472-6823